Combined Effects of Lion's Breath Technique With Chest Percussion Therapy in Pneumonia Patients
1 other identifier
interventional
90
1 country
1
Brief Summary
This study will be randomized controlled trial with non-probability convenient sampling. Sample size will be 90,45 in each group. Outcome will be measured by using 6 minute walk test, Spirometry (FVC, FEV1/FVC and PEF), Functional Independence Measure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2024
CompletedFirst Submitted
Initial submission to the registry
March 4, 2024
CompletedFirst Posted
Study publicly available on registry
March 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 5, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2024
CompletedJuly 23, 2024
July 1, 2024
3 months
March 4, 2024
July 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
George respiratory questionnaire
The George respiratory questionnaire is Disease-specific instrument designed to measure the impact on overall health, daily life, and perceived well-being in patients with obstructive airways disease. Total 50 items, 2 parts (3 components). Part 1 : Symptoms component (frequency \& severity) with a 1, 3 or 12-month recall (best performance with 3- and 12-month recall); Part 2: Activities that cause or are limited by breathlessness; Impact components (social functioning, psychological disturbances resulting from airways disease) refer to current state as the recall. Part I (Symptoms): several scales; Part II (Activity and Impacts): dichotomous (true/false) except last question (4-point Likert scale) Scores range from 0 to 100, with higher scores indicating more limitations.
1 Week
Forced vital capacity (FVC)
Forced vital capacity (FVC) is the amount of air that can be forcibly exhaled from your lungs after taking the deepest breath possible. It's measured by spirometry
1 Week
Borg Dyspnea Scale
The borg dyspnea scale is a numerical scale that measures the intensity of breathlessness of fatigue. It will be used to assess the baseline and posttest symptoms of patients with respiratory and cardiac condition. This is a scale that asks you to rate the difficulty of your breathing. It starts at number 0 where your breathing is causing you no difficulty at all and progresses through to number 10 where your breathing difficulty is maximal
1 Week
Forced expiratory volume (FEV1)
Forced expiratory volume (FEV1) calculates the amount of air that a person can force out of their lungs in 1 second. it is measured using Spirometer.
1 Week
FEV1/FVC Ratio
The FEV1/FVC ratio is the ratio of the forced expiratory volume in the first one second to the forced vital capacity of the lungs. The normal value for this ratio is above 0.75-85, measured using Spirometer.
1 Week
Study Arms (2)
Experimental Group (Lion breath)
EXPERIMENTALLion's Breath Technique + Chest Percussion Therapy
Control Group (Routine treatment)
ACTIVE COMPARATORChest Percussion Therapy only
Interventions
Patients receive training in Lion's Breath Technique, emphasizing deep diaphragmatic breathing and controlled exhalation. Daily supervised Lion's Breath Technique sessions for 20 minutes for 1 week
Trained physiotherapists administer chest percussion therapy to mobilize secretions and improve lung function. Daily session for 30 minutes for 1 week.
Eligibility Criteria
You may qualify if:
- Patients in the post-acute phase of pneumonia recovery.
- Adults aged 18 years and above diagnosed with pneumonia.
- Both male and female will be included.
- Participants should be in stable health conditions to participate in the Study.
- Willing to comply with the study protocol
You may not qualify if:
- Patients with severe or life-threatening pneumonia requiring immediate intensive care
- Patients with physical or cognitive limitations
- Patients with a history of chronic respiratory conditions such as COPD, bronchitis, or asthma
- Pregnant or breastfeeding women
- Individuals with musculoskeletal or neurological conditions
- Patients with contraindications to chest percussion therapy, such as recent surgery or trauma to the chest area
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jinnah Hospital
Lahore, Punjab Province, 42000, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Muhammad Faizan Hamid, MS-CPPT
Riphah International University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2024
First Posted
March 20, 2024
Study Start
March 1, 2024
Primary Completion
June 5, 2024
Study Completion
June 15, 2024
Last Updated
July 23, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share